US Archives - Page 18 of 137 - European Medical Journal

Multiple Barriers Delay Radiation for Head and Neck Cancer

Timely initiation of postoperative radiation therapy (PORT) within 6 weeks of surgery is a critical factor in improving outcomes for patients with head and neck squamous cell carcinoma.

Global Analysis Reveals Rising Burden of Complex PTSD

Complex post-traumatic stress disorder (C-PTSD) affects nearly one in ten people worldwide, according to a new systematic review and meta-analysis examining community prevalence of this ICD-11 defined condition.

WCLC 2025: IFITM3 May Improve Immunotherapy Outcomes in SCLC

Interferon-induced transmembrane protein 3 (IFITM3) has been identified as a critical regulator of immunotherapy response in small cell lung cancer (SCLC), with new findings showing its potential role as both a predictive biomarker and therapeutic target.

Mpox Shifts to Global Threat with Evolving Spread

Mpox has rapidly transitioned from a neglected zoonosis to a global health concern, with recent outbreaks reshaping its epidemiology, clinical features, and management strategies.

Bone Density After Hip Surgery Mostly Unchanged

Bone mineral density (BMD) assessment using radiofrequency echographic multispectrometry (REMS) shows that age, sex, and BMI remain the strongest determinants of bone health, even in the context of total hip replacement surgery.

Scalp Metastases from Breast Cancer Show Distinct Dermoscopic Patterns

Scalp cutaneous metastases from breast carcinoma may present with varied clinical patterns, and new research highlights distinct dermoscopic features that could aid earlier recognition.

10 Sep 2025

Alzheimer’s Diagnosis Dilemma: How Do You Confirm the Presence of Amyloid?

When evaluating patients with cognitive impairment, early confirmation of amyloid can change the course of care, yet the tools to do so…

Managing Ocular Side Effects of ADCs in Gynecologic Cancer

Ocular toxicities are an emerging challenge in the management of gynecologic cancers treated with antibody drug conjugates, with new research outlining prevention and care strategies to safeguard patient outcomes.

Schizophrenia Diagnosis Reframed in ICD-11 Criteria

The transition from ICD-10 to ICD-11 has introduced substantial revisions in the classification of schizophrenia and catatonia, reshaping diagnostic approaches for clinicians worldwide.

WCLC 2025: DLL3 Therapy Shows Promise in Relapsed SCLC

A first-in-human trial has demonstrated encouraging clinical activity and manageable safety for the DLL3-targeted antibody-drug conjugate SHR-4849 in patients with relapsed small cell lung cancer (SCLC).